CDKN2A and neoplasm: A p16-Ki-67-HMB45 total score from 0 to 9 permitted to classify nevi (score <4) and primary melanomas (score ≥4) with a sensitivity of 97.4 % and a specificity of 97.3 % in the first set of tumours.